Lymphopenia is Not the Primary Therapeutic Mechanism of Diroximel Fumarate in Relapsing–Remitting Multiple Sclerosis: Subgroup Analyses of the EVOLVE-MS-1 Study

MS Treatments

Jahr

Publikationsjahr
2024

Autoren

Autorenliste der Publikation
Singer BA, Wray S, Gudesblatt M, Bumstead B, Ziemssen T, Bonnell A, Scaramozza M, Levin S, Shanmugasundaram M, Chen H, Mendoza JP, Lewin JB, Shankar SL.

Verlag

Publisher-Information
Neurol Ther. 2024 Jun 27.

Link

Zur Publikation (externer Server)
https://doi.org/10.1007/s40120-024-00637-2

Tags

Forschungsthemen
Multiple SkleroseMS Behandlung
MSZTreatments2024